Xie Y W, Wolin M S
Department of Physiology, New York Medical College, Valhalla 10595, USA.
Circulation. 1996 Nov 15;94(10):2580-6. doi: 10.1161/01.cir.94.10.2580.
Nitric oxide (NO); superoxide anion (O2.d-); the reaction product of NO with O2.d-, peroxynitrite (ONOO-); and ischemia/reperfusion have all been reported to inhibit respiration in isolated mitochondria. However, the specific species involved in the inhibition of respiration in intact tissues are poorly understood.
O2 consumption in isolated cardiac muscle from bovine calf hearts was quantified by use of a Clark-type electrode. Exogenous and endogenous sources of NO, from S-nitroso-N-acetylpenicillamine (SNAP) and bradykinin or carbachol, reversibly inhibited respiration, whereas the O2.- releasing agent, pyrogallol (PG), inhibited respiration in a manner that was only partially reversed when examined 15 minutes after the removal of PG. The generation of ONOO- with SNAP + PG caused a potentiation of the O2(-)-elicited inhibition of respiration when examined 15 minutes after the removal of the ONOO- generating system. Tiron (a scavenger of O2.-) did not alter the actions of SNAP, but it attenuated the direct inhibitory effects of PG +/- SNAP and essentially eliminated the suppression of respiration observed 15 minutes after removal of the O2.- or ONOO- generating system. Urate (a scavenger of ONOO-) antagonized only the actions of PG + SNAP. After exposure of muscle slices to a model of hypoxia (15 minutes) and reoxygenation (10 minutes), respiratory inhibition was observed. This reoxygenation-induced inhibition was potentiated by L-arginine, the substrate for NO biosynthesis, and was markedly blocked by nitro-L-arginine (an NO synthase inhibitor), Tiron, or urate.
The potentially physiological reversible regulation of respiration in cardiac muscle by NO is converted to an effect that does not show rapid reversibility under conditions in which ONOO- forms, and this could contribute to cardiac dysfunction in situations such as hypoxia/reoxygenation.
一氧化氮(NO)、超氧阴离子(O₂⁻)、NO与O₂⁻的反应产物过氧亚硝酸盐(ONOO⁻)以及缺血/再灌注均已被报道可抑制离体线粒体的呼吸作用。然而,完整组织中参与呼吸抑制的具体物质却知之甚少。
使用Clark型电极对来自小牛心脏的离体心肌中的氧气消耗进行定量分析。外源性和内源性的NO来源,即S - 亚硝基 - N - 乙酰青霉胺(SNAP)以及缓激肽或卡巴胆碱,均可可逆地抑制呼吸作用,而释放O₂⁻的试剂邻苯三酚(PG)抑制呼吸作用的方式在去除PG 15分钟后检测时仅部分可逆。当在去除ONOO⁻生成系统15分钟后检测时,SNAP + PG生成的ONOO⁻会增强O₂⁻引起的呼吸抑制作用。替诺(一种O₂⁻清除剂)不会改变SNAP的作用,但它减弱了PG +/- SNAP的直接抑制作用,并基本消除了在去除O₂⁻或ONOO⁻生成系统15分钟后观察到的呼吸抑制作用。尿酸盐(一种ONOO⁻清除剂)仅拮抗PG + SNAP的作用。将肌肉切片暴露于缺氧(15分钟)和复氧(10分钟)模型后,观察到呼吸抑制。这种复氧诱导的抑制作用被NO生物合成的底物L - 精氨酸增强,并被硝基 - L - 精氨酸(一种NO合酶抑制剂)、替诺或尿酸盐显著阻断。
在ONOO⁻形成的条件下,NO对心肌呼吸作用潜在的生理性可逆调节转变为一种不显示快速可逆性的效应,这可能导致诸如缺氧/复氧等情况下的心脏功能障碍。